CRISM Therapeutics Company Description

CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs in the British Virgin Islands.

The company’s lead product is ChemoSeed, which can be implanted directly into the tumour or the resection margin following the removal of a tumour.

It also provides formulation and consultancy services. The company was formerly known as Amur Minerals Corporation and changed its name to CRISM Therapeutics Corporation in May 2024.

CRISM Therapeutics Corporation is based in Road Town, the British Virgin Islands.

CRISM Therapeutics Corporation

Country	British Virgin Islands
Founded	2016
Industry	Biotechnology
Sector	Healthcare
Employees	4
CEO	Andrew Webb

Contact Details

Address: Kingston Chambers Road Town British Virgin Islands
Website	crismtherapeutics.com

Stock Details

Ticker Symbol	CRTX
Exchange	London Stock Exchange AIM
Fiscal Year	January - December
Reporting Currency	GBP
ISIN Number	VGG042401262
SIC Code	2836

Key Executives

Name	Position
Andrew Webb	Chief Executive Officer
Ae Swanson	Chief Operating Officer